Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aquestive Therapeutics | 583.72 Mn | 583.72 Mn | 9.80 Mn | 28.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.56% |
| Mar 31, 2026 | 74.51% |
| Dec 31, 2025 | -674.27% |
| Sep 30, 2025 | -335.36% |
| Jun 30, 2025 | -23,879.54% |
| Mar 31, 2025 | -143.09% |
| Dec 31, 2024 | 66.38% |
| Sep 30, 2024 | -69.20% |
| Jun 30, 2024 | 101.45% |
| Mar 31, 2024 | -118.46% |
| Dec 31, 2023 | -4.09% |
| Sep 30, 2023 | 83.31% |
| Jun 30, 2023 | 90.31% |
| Mar 31, 2023 | 85.11% |
| Dec 31, 2022 | -4.38% |
| Sep 30, 2022 | -61.98% |
| Jun 30, 2022 | -176.01% |
| Mar 31, 2022 | 9.11% |
| Dec 31, 2021 | -18.37% |
| Sep 30, 2021 | 60.96% |